Rizia Bardhan

  • Vanderbilt University

    Novel, ‘multiplexed’ diagnosis may better identify candidates for cancer immunotherapy

    A Vanderbilt engineering researcher has shown that combining an enhanced vibrational spectroscopy technique with tagged gold nanostructures can detect important tumor immunomarkers – a significant step toward predicting which patients would benefit from immunotherapy. The study by Rizia Bardhan, assistant professor of chemical and biomolecular engineering, involved breast tumors… Read More

    Aug. 26, 2018

  • Vanderbilt University

    Bardhan awarded prestigious career development grant for melanoma research

    A Vanderbilt engineering researcher has shown that combining an enhanced vibrational spectroscopy technique with tagged gold nanostructures can detect important tumor immunomarkers – a significant step toward predicting which patients would benefit from immunotherapy. The study by Rizia Bardhan, assistant professor of chemical and biomolecular engineering, involved breast tumors… Read More

    Mar. 23, 2018

  • Vanderbilt University

    Size matters in nanocrystals’ ability to adsorb/release gases

    A Vanderbilt engineering researcher has shown that combining an enhanced vibrational spectroscopy technique with tagged gold nanostructures can detect important tumor immunomarkers – a significant step toward predicting which patients would benefit from immunotherapy. The study by Rizia Bardhan, assistant professor of chemical and biomolecular engineering, involved breast tumors… Read More

    Aug. 6, 2013

  • Vanderbilt University

    New faculty: Rizia Bardhan finds solutions at the nanoscale

    A Vanderbilt engineering researcher has shown that combining an enhanced vibrational spectroscopy technique with tagged gold nanostructures can detect important tumor immunomarkers – a significant step toward predicting which patients would benefit from immunotherapy. The study by Rizia Bardhan, assistant professor of chemical and biomolecular engineering, involved breast tumors… Read More

    Dec. 11, 2012